Vincent Cottin

TL;DR: Although most topics relate to rare pulmonary diseases, representing the core of the Congress, this year several rare presentations of common respiratory diseases are presented.

TL;DR: Pulmonary fibrosis in the setting of rheumatoid arthritis is an example of genotype–environment interaction and involves multiple mechanisms including autoimmunity, inflammation, and fibrogenesis, which should be paid to potential lung toxicity of RA treatment.

TL;DR: In a subgroup analysis of pooled data from the INPULSIS® trials, nintedanib reduced the annual decline in lung function in patients with IPF independent of corticosteroid use at baseline.

TL;DR: This article reviews a selection of scientific presentations at the 2012 European Respiratory Society Annual Congress in Vienna, Austria, dealing with the areas of chronic obstructive pulmonary disease, the diagnosis and management of idiopathic pulmonary fibrosis, sarcoidosis, endobronchial techniques in emphysema, functional imaging and issues in respiratory medicine relevant for the primary care setting.

TL;DR: Findings in the PASSPORT study were consistent with the known safety profile of pirfenidone, with no new safety signals observed.